Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corcept Therapeutics

74.45
-4.9200-6.20%
Post-market: 74.42-0.0300-0.04%19:38 EDT
Volume:2.54M
Turnover:189.32M
Market Cap:7.85B
PE:60.53
High:78.00
Open:77.60
Low:72.59
Close:79.37
Loading ...

Corcept Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
03 Apr

Form 4 | CORCEPT THERAPEUTICS INC Officer Joseph Douglas Lyon sold 200,650 Shares.

SEC Track
·
03 Apr

Biotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & More

Zacks
·
03 Apr

Does Corcept (CORT) Have the Potential to Rally 28.63% as Wall Street Analysts Expect?

Zacks
·
02 Apr

APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag

Zacks
·
02 Apr

CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer Study Goal

Zacks
·
01 Apr

Corcept Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
01 Apr

SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States

Zacks
·
01 Apr

AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication

Zacks
·
01 Apr

Why Corcept Therapeutics Incorporated (CORT) Went Up On Monday?

Insider Monkey
·
01 Apr

Canaccord Genuity Sticks to Its Buy Rating for Corcept Therapeutics (CORT)

TIPRANKS
·
01 Apr

Corcept Therapeutics Inc : Piper Sandler Raises Target Price to $128 From $78

THOMSON REUTERS
·
01 Apr

Small U.S. Stocks End Mixed As Corcept Therapeutics Lead, LZ Technology Holdings Lags

Dow Jones
·
01 Apr

Equity Markets Mixed Ahead of Tariff Announcements

MT Newswires Live
·
01 Apr

Why Is Corcept (CORT) Stock Soaring Today

StockStory
·
01 Apr

Corcept Therapeutics (NasdaqCM:CORT) Reports Positive Phase 3 Results Despite 8% Share Price Dip

Simply Wall St.
·
01 Apr

Top Midday Gainers

MT Newswires Live
·
01 Apr

Corcept Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
01 Apr

Piper Sandler Raises Corcept Therapeutics' Price Target to $128 From $78, Maintains Overweight Rating

MT Newswires Live
·
31 Mar

Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet

Benzinga
·
31 Mar